Mass Transport through Carbon Nanotube Membranes in Three Different Regimes: Ionic Diffusion and Gas and Liquid Flow

ACS Nano ◽  
2011 ◽  
Vol 5 (5) ◽  
pp. 3867-3877 ◽  
Author(s):  
Mainak Majumder ◽  
Nitin Chopra ◽  
Bruce J. Hinds
2008 ◽  
Vol 316 (1-2) ◽  
pp. 89-96 ◽  
Author(s):  
Mainak Majumder ◽  
Karin Keis ◽  
Xin Zhan ◽  
Corey Meadows ◽  
Jeggan Cole ◽  
...  

Small ◽  
2007 ◽  
Vol 3 (12) ◽  
pp. 1996-2004 ◽  
Author(s):  
Henk Verweij ◽  
Melissa C. Schillo ◽  
Ju Li

2014 ◽  
Vol 16 (8) ◽  
pp. 082001 ◽  
Author(s):  
A Popadić ◽  
J H Walther ◽  
P Koumoutsakos ◽  
M Praprotnik

2009 ◽  
Vol 3 ◽  
pp. SART.S1050
Author(s):  
Caroline L. Strasinger ◽  
Nicole N. Scheff ◽  
Ji Wu ◽  
Bruce J. Hinds ◽  
Audra L. Stinchcomb

Transdermal systems are attractive methods of drug administration specifically when treating patients for drug addiction. Current systems however are deficient in therapies that allow variable flux values of drug, such as nicotine for smoking cessation or complex dosing regimens using clonidine when treating opioid withdrawal symptoms. Through the use of functionalized carbon nanotube (CNT) membranes, drug delivery to the skin can be controlled by applying a small electrical bias to create a programmable drug delivery system. Clearly, a transdermal patch system that can be tailored to an individual's needs will increase patient compliance as well as provide much more efficient therapy. The purpose of this paper is to discuss the applicability of using carbon nanotube membranes in transdermal systems for treatment of drug abuse.


Sign in / Sign up

Export Citation Format

Share Document